Travere Therapeutics Inc. (TVTX)
NASDAQ: TVTX
· Real-Time Price · USD
15.01
0.17 (1.15%)
At close: Jul 03, 2025, 1:04 PM
15.01
0.00%
After-hours: Jul 03, 2025, 04:20 PM EDT
1.15% (1D)
| Bid | 14 |
| Market Cap | 1.33B |
| Revenue (ttm) | 273.53M |
| Net Income (ttm) | -226.71M |
| EPS (ttm) | -2.78 |
| PE Ratio (ttm) | -5.4 |
| Forward PE | 25.27 |
| Analyst | Buy |
| Ask | 15.1 |
| Volume | 663,493 |
| Avg. Volume (20D) | 1,713,657 |
| Open | 14.86 |
| Previous Close | 14.84 |
| Day's Range | 14.84 - 15.09 |
| 52-Week Range | 7.72 - 25.29 |
| Beta | 0.74 |
About TVTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TVTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TVTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Travere Therapeutics Inc. is scheduled to release its earnings on Jul 31, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-20.57%
Travere Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
1 month ago
+0.28%
Travere Therapeutics shares are trading lower. The company announced that the FDA accepted its supplemental New Drug Application for traditional approval of FILSPARI for the treatment of focal segmental glomerulosclerosis.
